11 Feb 2026 | 04:00 PM GMT

Prior Authorization 2.0: From Pilots to Mandates

Participants:

Seema Verma Executive Vice President & General Manager OrOracle
Seema Verma
Executive Vice President & General Manager OrOracle
Louise Nixon Program ManagerHLTH
Louise Nixon
Program ManagerHLTH
Aalpen Patel Chief Clinical and Innovation OfficerMedQuest Imaging
Aalpen Patel
Chief Clinical and Innovation OfficerMedQuest Imaging
Alice Murphy Community ManagerHLTH
Alice Murphy
Community ManagerHLTH
Brittany Crosby Director of Product ManagementPfizer
Brittany Crosby
Director of Product ManagementPfizer
Devan Flores CEO/ FounderSerene
Devan Flores
CEO/ FounderSerene
EA
Emily Abraham Director, Strategic PartnershipsTakeda
EA
Emily Abraham
Director, Strategic PartnershipsTakeda
James York SurgeonLuminis Health
James York
SurgeonLuminis Health
Kelly Murphy Medical Director, Quality and Care ManagementCHOC Health Alliance, Rady Children's Health
Kelly Murphy
Medical Director, Quality and Care ManagementCHOC Health Alliance, Rady Children's Health
Kenzie Mucci Digital Partnership LeadTakeda
Kenzie Mucci
Digital Partnership LeadTakeda
Laura Bravo Director, Digital Health & Consumer Eng.AltaMed
Laura Bravo
Director, Digital Health & Consumer Eng.AltaMed
MD
Michelle Donnelly Strategic PartnershipsTakeda
MD
Michelle Donnelly
Strategic PartnershipsTakeda
Sebastian Judez Head of Proposition and MedicalAXA Health International
Sebastian Judez
Head of Proposition and MedicalAXA Health International
Thibault DEMOURES Global head of Individual IPMIAXA
Thibault DEMOURES
Global head of Individual IPMIAXA
Valentine Emmanuel G. CEOSynduct
Valentine Emmanuel G.
CEOSynduct
Vivian Cheung VP Patient AccessFamily Health Centers San Diego
Vivian Cheung
VP Patient AccessFamily Health Centers San Diego

About this Meeting

Few processes have generated as much frustration across healthcare as prior authorization. Long criticized for delaying care and burdening clinicians, it now stands at the center of one of the most significant policy-driven technology shifts in years. With CMS’s 2026 Interoperability and Prior Authorization Final Rule now in effect, payers and providers must move from small-scale pilots to enterprise-wide automation — transforming how approvals are requested, reviewed, and recorded.

This roundtable explores what real-world implementation looks like as the rule goes live: how organizations are managing data integration, clinician adoption, and oversight; where AI and workflow automation are delivering early wins; and what pitfalls persist around bias, transparency, and interoperability. Participants will hear first-hand lessons from early adopters on achieving measurable gains in speed, equity, and compliance — and how to ensure automation enhances rather than complicates the patient experience.

Join us to discuss:

  • What lessons are early adopters sharing from first-wave compliance and automation efforts?

  • How can AI and interoperability tools accelerate approvals while maintaining transparency and trust?

  • What metrics and dashboards best capture improvements in efficiency, equity, and patient experience?